At the Spanish National Congress of Urology held in Salamanca from 10 to 13 June, OPKO Health presented its latest clinical results for 4Kscore®, the diagnostic blood test that assesses an individual patient’s risk for aggressive prostate cancer.
The information on this page is intended only for healthcare professionals. Therefore, a specialized training is required to interpret it properly. If you are not a qualified healthcare professional, OPKO Health Spain S.L.U. accepts no responsibility for any harm that may arise from your adopted decisions, based on this page content or any of its links.